There are 2789 resources available
Full session recording
Presenter: Heather Payne
Session: Astellas - The evolving landscape of advanced prostate cancer
Resources:
Webcast
Altering outcomes for rare tumors with new treatment options
Presenter: Mrinal Gounder
Session: Boehringer Ingelheim - CTRL + ALT + DEL: Disrupting Cancer’s Operating Functions
Resources:
Webcast
Rebooting checkpoint inhibition with smart combinations
Presenter: Hossein Borghaei
Session: Boehringer Ingelheim - CTRL + ALT + DEL: Disrupting Cancer’s Operating Functions
Resources:
Webcast
Deleting tumors through novel approaches to ramp up the immune system
Presenter: Ulrich Lauer
Session: Boehringer Ingelheim - CTRL + ALT + DEL: Disrupting Cancer’s Operating Functions
Resources:
Webcast
Closing and Key Takeaways
Presenter: Egbert F. Smit
Session: Boehringer Ingelheim - CTRL + ALT + DEL: Disrupting Cancer’s Operating Functions
Resources:
Webcast
Welcome and introduction
Presenter: Thierry André
Session: GSK - Biomarkers for cancer immunotherapy: the importance of dMMR/MSI-H for predicting response in solid tumors
Resources:
Webcast
Welcome and Introduction to Topics and Speakers
Presenter: Egbert F. Smit
Session: Boehringer Ingelheim - CTRL + ALT + DEL: Disrupting Cancer’s Operating Functions
Resources:
Webcast
Controlling cancer cell hallmarks to deliver breakthrough therapies
Presenter: Egbert F. Smit
Session: Boehringer Ingelheim - CTRL + ALT + DEL: Disrupting Cancer’s Operating Functions
Resources:
Webcast
Biomarkers for treatment with immune checkpoint inhibitors. Where are we now?
Presenter: Josef Rüschoff
Session: GSK - Biomarkers for cancer immunotherapy: the importance of dMMR/MSI-H for predicting response in solid tumors
Resources:
Webcast
Efficacy and safety of immune checkpoint inhibitors in patients with dMMR/MSI-H advanced/recurrent endometrial cancer
Presenter: Anna Tinker
Session: GSK - Biomarkers for cancer immunotherapy: the importance of dMMR/MSI-H for predicting response in solid tumors
Resources:
Webcast